Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    85,681.48
    -2,578.36 (-2.92%)
     

  • CMC Crypto 200

    1,307.65
    -88.89 (-6.37%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

New Strong Buy Stocks for December 19th

Tirthankar Chakraborty

Here are 3 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

CIRCOR International, Inc. (CIR): This company that designs, manufactures, and markets engineered products and sub-systems has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.

CIRCOR International, Inc. Price and Consensus

 

CIRCOR International, Inc. Price and Consensus
CIRCOR International, Inc. Price and Consensus

CIRCOR International, Inc. price-consensus-chart | CIRCOR International, Inc. Quote

Edwards Lifesciences Corporation (EW): This company that provides products and technologies for structural heart disease and critical care monitoring has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.1% over the last 60 days.

ADVERTISEMENT

Edwards Lifesciences Corporation Price and Consensus

 

Edwards Lifesciences Corporation Price and Consensus
Edwards Lifesciences Corporation Price and Consensus

Edwards Lifesciences Corporation price-consensus-chart | Edwards Lifesciences Corporation Quote

Zynerba Pharmaceuticals, Inc. (ZYNE): This clinical stage specialty pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.

Zynerba Pharmaceuticals, Inc. Price and Consensus

 

Zynerba Pharmaceuticals, Inc. Price and Consensus
Zynerba Pharmaceuticals, Inc. Price and Consensus

Zynerba Pharmaceuticals, Inc. price-consensus-chart | Zynerba Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Zynerba Pharmaceuticals, Inc. (ZYNE) : Free Stock Analysis Report
 
Edwards Lifesciences Corporation (EW) : Free Stock Analysis Report
 
CIRCOR International, Inc. (CIR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research